CSS
AMPE

Cubist Systematic Strategies’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Cubist Systematic Strategies’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60
Closed -$3K – 5018
2022
Q2 		$3K Buy
+60
New +$4.47K ﹤0.01% 4316
2021
Q3 		– Sell
-124
Closed -$62K – 3283
2021
Q2 		$62K Sell
124
-496
-80% -$266K ﹤0.01% 2768
2021
Q1 		$314K Buy
620
+575
+1,278% +$297K ﹤0.01% 2228
2020
Q4 		$22K Buy
+45
New +$14.8K ﹤0.01% 2498

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Cubist Systematic Strategies's AMPE Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 60 shares — an estimated $3K sold.

Cubist Systematic Strategies first reported a position in AMPE in Q4 2020 and held it in 4 quarters. The position peaked at $314K in Q1 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 60 Ampio Pharmaceuticals Inc. shares in Q3 2022, an estimated $3K.
  • Cubist Systematic Strategies first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 4 quarters.
  • Cubist Systematic Strategies's Ampio Pharmaceuticals Inc. position peaked at $314K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.